|
The Scottish Government Health Directorates Capital Investment Group (CIG) oversees the approval process for business cases across NHSScotland where the value of the capital project is greater than the delegated limit. This role covers all infrastructure investment regardless of the ultimate funding route pursued by the procuring organisation.
By approving the business cases submitted to it, the CIG gives NHSScotland bodies the assurance of Health Directorates support for the strategic justification for progressing capital schemes whilst sending a clear indication to the private sector of the projects which are supported by SGHD. The CIG role is vital in providing the necessary assurances to both Ministers and SGHD Management Board that proposals are robust, affordable and deliverable.
An assessment of design quality is now part of the SGHD Business Case process. All projects submitted to the SGHD Capital Investment Group for approval are now subject to an assessment of design quality and functionality, including technical and sustainability standards. This Design Assessment will take during latter stages of development of the Initial Agreement, Outline Business Case and Full Business Case; the assessment to be carried out prior to formal consideration by the Health Board and before the business case is submitted to CIG. Guidance on the Design Assessment process has been added to the Scottish Capital Investment Manual.
|
